Sage’s medical chief is latest leader to leave biotech
As Sage Therapeutics Inc. contemplates its path forward after rejecting a buyout offer from Biogen, its top executive ...
Sage Therapeutics Announces R&D Leadership Transition
Sage Therapeutics, Inc. (Nasdaq: SAGE) today announced that Dr. Laura Gault, Chief Medical Officer, has decided to pursue a new opportunity and will depart the Company, effective March 21, 2025. Dr.
Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Consensus Rating of “Hold” by Analysts
Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) has been given a consensus recommendation of “Hold” by the nineteen ratings firms that are currently covering the stock, MarketBeat.com reports.
Sage Therapeutics, Inc. (SAGE): Among the Best Psychedelic Stocks to Buy in 2025
We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...
Sage Therapeutics Chief Medical Officer to step down
Sage Therapeutics (SAGE) announced that Dr. Laura Gault, Chief Medical Officer, has decided to pursue a new opportunity and will depart the ...
Is Sage Therapeutics, Inc. (SAGE) the Best Small-Cap Growth Stock to Buy Now?
We recently published a list of 10 Best Small-Cap Growth Stocks to Buy Now. In this article, we are going to take a look at ...
Are Small-Cap Stocks Poised for Growth?
We recently published a list of 10 Best Small-Cap Growth Stocks to Buy Now. In this article, we are going to take a look at ...
Insider Monkey9d
10 Best Small-Cap Growth Stocks to Buy Now
Sage Therapeutics, Inc. (NASDAQ:SAGE) is a biopharmaceutical company specializing in developing solutions for brain health disorders. Its key products include ZURZUVAE, which is a neuroactive ...
The Therapeutic Potential and Investment Boom in Psychedelic Medicine
We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...